Fisher G R, Patterson L H
Department of Pharmacy, Leicester Polytechnic, U.K.
Cancer Chemother Pharmacol. 1992;30(6):451-8. doi: 10.1007/BF00685596.
The MCF-7 cell S9 fraction and whole MCF-7 cells can mediate one-electron-redox cycling of doxorubicin, giving rise to concomitant oxidation of reduced nicotinamide adenine dinucleotide phosphate (NADPH), formation of a drug semiquinone free radical, consumption of molecular oxygen and formation of superoxide anions and hydroxyl radicals. Doxorubicin redox cycling was consistent with DNA strand breakage and cell kill in MCF-7 cells. In contrast, no evidence for redox cycling was found for mitoxantrone (MIT), CI941 or ametantrone (AMET) in MCF-7 cells. Despite the absence of redox cycling, the CI941, MIT, and AMET concentrations resulting in 50% mortality (LC50; 1.5 x 10(-10), 5.2 x 10(-9) and 1.2 x 10(-6) M, respectively) of MCF-7 cells were lower than that of DOX (3.0 x 10(-6) M). Furthermore, the higher cytotoxicity of MIT and CI941 as compared with AMET or DOX was associated with greater efficiency in inducing DNA strand breakage in MCF-7 cells as determined by alkaline elution. Since MIT and CI941 proved to be the most potent DNA-damaging and cytotoxic agents in this study, the ability of DOX to undergo redox cycling does not appear to confer increased cytotoxic potential on this agent. The present study revealed several important aspects with regards to the structural modification of anthraquinone antitumour agents. Firstly, the C1 and C4 positioning of the hydroxyethylamino side chains on MIT, CI941 and AMET is associated with a lack of flavin reductase-mediated activation of these agents. Secondly, the possession of a C5 or C8 aromatic hydroxyl group appears to be intimately involved in the enhanced DNA strand breakage and cytotoxic potency of MIT and CI941, since AMET does not possess these groups. These findings indicate that future development of quinone antitumour agents should concentrate on compounds that do not undergo redox cycling but do possess aromatic hydroxyl groups, since the latter appear to be responsible for the enhanced cytotoxicity of MIT and CI941.
MCF-7细胞S9组分和完整的MCF-7细胞能够介导阿霉素的单电子氧化还原循环,导致还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)伴随氧化、药物半醌自由基形成、分子氧消耗以及超氧阴离子和羟基自由基形成。阿霉素氧化还原循环与MCF-7细胞中的DNA链断裂和细胞杀伤一致。相比之下,在MCF-7细胞中未发现米托蒽醌(MIT)、CI941或氨甲蒽醌(AMET)存在氧化还原循环的证据。尽管不存在氧化还原循环,但导致MCF-7细胞50%死亡率(LC50;分别为1.5×10⁻¹⁰、5.2×10⁻⁹和1.2×10⁻⁶ M)的CI941、MIT和AMET浓度低于阿霉素(3.0×10⁻⁶ M)。此外,通过碱性洗脱测定,与AMET或阿霉素相比,MIT和CI941更高的细胞毒性与诱导MCF-7细胞DNA链断裂的更高效率相关。由于在本研究中MIT和CI941被证明是最有效的DNA损伤和细胞毒性剂,阿霉素进行氧化还原循环的能力似乎并未赋予该药物增加的细胞毒性潜力。本研究揭示了关于蒽醌类抗肿瘤药物结构修饰的几个重要方面。首先,MIT、CI941和AMET上羟乙氨基侧链的C1和C4定位与这些药物缺乏黄素还原酶介导的活化有关。其次,拥有C5或C8芳香羟基似乎与MIT和CI941增强的DNA链断裂和细胞毒性效力密切相关,因为AMET不具备这些基团。这些发现表明,醌类抗肿瘤药物的未来开发应集中于不进行氧化还原循环但确实拥有芳香羟基的化合物,因为后者似乎是MIT和CI941细胞毒性增强的原因。